-
Global Business Expansion Buildup ① - Japan Market Trend Analysis and Global BD Success Cases 2026.08.25 (14:00 - 17:00) l E1 세미나룸 (Hall E) Korea Institute of Toxicology(KIT)), HekaBio K.K. Robert E. Claar, CEO Detail View
-
ADC(항체-약물 접합체) 혁신기술소개 2026.08.25 (10:25 - 10:40) | The Platz Hall Seminar Room Cyron Therapeutics Sangsoon Yoon, CEO Detail View
-
National Bio Innovation Committee: Policy Directions for Supporting the Pharmaceutical and Biohealth Industries 2026.08.26 (10:40 - 11:25) | 3F Conference Room 318 National Bio Innovation Committee Kyungwon Seo, Member Detail View
-
Strategies for Building a Technology Commercialization Ecosystem in the Pharmaceutical and Biotechnology Industries 2026.08.26 (11:25 - 12:00) | 3F Conference Room 318 Science & TEchnology Policy Institute Soojeong Sohn, Research Fellow Detail View
-
Global Pharmaceutical and Biotechnology Innovation Trends and Support Policies in Key Countries 2026.08.26 (13:30 - 14:00) | 3F Conference Room 318 Pharmaceutical Strategy Institute Yoontaek Jung, CEO Detail View
-
Industry Challenges and Recommendations in the Pharmaceutical and Biohealth Sectors
: Survey Results on Industry Support Policies and Challenges for the National Bio Innovation Committee’s Policy Agenda 2026.08.26 (14:00 - 14:30) | 3F Conference Room 318 Korea Drug Research Association (KDRA) Hunche Cho, Executive Director Detail View -
Implementation Strategies for Advancing the Drug Development Ecosystem 2026.08.26 (14:30 - 15:00) | 3F Conference Room 318 Hanlim Pharm Jaejoon Woo, CIO Detail View
-
When you deform the skin, where does the drug go? Computational and Experimental Analysis of Drug Delivery via Microneedles 2026.08.27 (15:50 - 16:30) | 3F Conference Room 318 University College Dublin Eoin Ó Cearbhaill, Associate Professor Detail View
E-3
| Title | Global Business Expansion Buildup ① - Japan Market Trend Analysis and Global BD Success Cases |
|---|---|
| Date | 2026.08.25 (14:00 - 17:00) l E1 세미나룸 (Hall E) |
| Organization | Korea Institute of Toxicology(KIT)), HekaBio K.K. |
| Speaker | Robert E. Claar, CEO |
Speaker & Lecture Information
[Brief Introduction of Seminar]
Building a Foundation for Global Market Entry
[Brief Introduction of Speaker]
Rob Claar is a healthcare business leader focused on advancing solutions that address the unmet needs of patients, clinicians, innovators, regulators, and payors, with a particular emphasis on improving access to Japan’s healthcare market.
Over the past three decades, he has built and led multiple healthcare ventures across Japan, Europe, and the United States, including Junicon, which established Japan’s first comprehensive KOL physician network, and Vorpal Technologies, a leader in MedTech regulatory approvals in Japan.
He is recognized for building long-standing, global relationships across the MedTech and pharmaceutical sectors, grounded in trust, disciplined execution, and collaboration.
